Literature DB >> 35502049

Commentary: Applicability of optical coherence tomography angiography for imaging ocular biomarkers of systemic diseases.

Jay Umed Sheth1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35502049      PMCID: PMC9332956          DOI: 10.4103/ijo.IJO_247_22

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   2.969


× No keyword cloud information.
Optical coherence tomography angiography (OCTA) is a relatively new imaging modality that is primarily used to assess the microvascular network of the retina, choroid, and optic disc.[1] It allows for a dyeless and non-invasive evaluation of the vasculature in a variety of chorioretinal vascular disorders.[1] Researchers can use OCTA to look at quantitative factors such as the foveal avascular zone (FAZ) area, superficial capillary plexus vessel density (SCP VD), deep capillary plexus vessel density (DCP VD), vascular length density (VLD), and acircularity index (AI).[1] Given its non-invasive nature and ability to create high-quality reproducible images, this imaging technique is gaining appeal among Vitreoretinal Specialists. The retina is an incredibly easy and accessible organ to image the internal structure of the human body because of the architecture of the eye.[2] The condition of the vasculature throughout the body is presumed to be comparable to that of the retinal blood vessels.[2] As a result, the status of systemic disease can be monitored based on retinal blood vessel examination.[2] This is especially true in neurological disorders since the vascular architecture of the brain and retina twin to a great extent.[3] The extent of OCTA abnormalities has been shown to correlate with the severity of various neurodegenerative and neurovascular diseases, such as Alzheimer’s disease, multiple sclerosis (MS), Parkinson’s disease, migraines, papilledema, arteritic and non-arteritic optic neuropathy (AION and NAION), Leber’s hereditary optic neuropathy (LHON), amyotrophic lateral sclerosis (ALS), Huntington’s disease, and so on.[3] The role of OCTA is slowly evolving in other fields such as cardiology, pulmonology, nephrology, and diabetology.[234567] Amongst them, diabetic and hypertensive patients have been extensively studied with OCTA. Using OCTA, Diabetics without diabetic retinopathy (DR) were found to have decreased superficial and deep retinal VD with increased areas of FAZ and nonperfusion when compared to healthy participants.[8] Furthermore, OCTA evaluation can be used to predict an elevated risk of developing diabetic macular edema (DME) and DR progression.[4] A similar reduction in the VD and FAZ enlargement has also been demonstrated in hypertensive patients.[7] Indeed, Lee et al.[2] demonstrated comparable alterations on OCTA in patients with chronic hypertension who had and did not have clinical abnormalities of hypertensive retinopathy (HTR), emphasizing the importance and sensitivity of this imaging modality. In some pulmonological disorders, retinal vascular changes may occur as a result of secondary changes caused by systemic inflammation and hypoxia rather than as a direct result of the original microvascular pathology.[6] In their study on evaluation of retinal and optic disc microvascular changes in patients with stable chronic obstructive pulmonary disease (COPD), Kurtul et al.[6] showed the severity of COPD to have a negative impact on OCTA parameters, including the VD in the superficial and deep retinal plexuses. Although the study is limited by a small sample size, the results presented are very interesting, and further studies with a larger sample size and longer follow-up are needed to validate the results and further explore this relationship.[6] Thus, it can be observed that OCTA provides a considerable amount of valuable information about the vascular status of the retina and throughout the body. Since OCTA is a highly sensitive imaging modality, it can detect subtle changes in vascular perfusion quite early.[1] These changes can be a surrogate biomarker in early systemic disease, especially in neurological conditions. Investigating the chronology of vascular alterations on OCTA in relation to structural changes could help answer fundamental questions about disease causation. Presently, numerous systemic disorders are being investigated by OCTA for their potential role in diagnosis and monitoring the therapeutic response.[2345678] Thus, the micromorphometry of the retinal, choroidal, and optic disc vasculature, as demarcated and quantified by the OCTA, may be a valuable biomarker for the management and prognosis of diseases, not only in the field of ophthalmology but also in other branches of medicine.
  8 in total

1.  Use of optical coherence tomography angiography for assessment of microvascular changes in the macula and optic nerve head in hypertensive patients without hypertensive retinopathy.

Authors:  Dihao Hua; Yishuang Xu; Xiangbing Zeng; Ning Yang; Mengnan Jiang; Xiao Zhang; Jiayi Yang; Tao He; Yiqiao Xing
Journal:  Microvasc Res       Date:  2019-12-23       Impact factor: 3.514

Review 2.  Optical coherence tomography angiography.

Authors:  Richard F Spaide; James G Fujimoto; Nadia K Waheed; Srinivas R Sadda; Giovanni Staurenghi
Journal:  Prog Retin Eye Res       Date:  2017-12-08       Impact factor: 21.198

3.  Retinal and choroidal vasculature changes associated with chronic kidney disease.

Authors:  Maria Vadalà; Massimo Castellucci; Giulia Guarrasi; Micol Terrasi; Tiziana La Blasca; Giuseppe Mulè
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-05-30       Impact factor: 3.117

4.  OCT Angiography Metrics Predict Progression of Diabetic Retinopathy and Development of Diabetic Macular Edema: A Prospective Study.

Authors:  Zihan Sun; Fangyao Tang; Raymond Wong; Jerry Lok; Simon K H Szeto; Jason C K Chan; Carmen K M Chan; Clement C Tham; Danny S Ng; Carol Y Cheung
Journal:  Ophthalmology       Date:  2019-06-26       Impact factor: 12.079

5.  Quantitative Retinal Optical Coherence Tomography Angiography in Patients With Diabetes Without Diabetic Retinopathy.

Authors:  Galina Dimitrova; Etsuo Chihara; Hirokazu Takahashi; Hiroyuki Amano; Kazushiro Okazaki
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

Review 6.  Optical Coherence Tomography Angiography in Neurodegenerative Diseases: A Review.

Authors:  Georgios Tsokolas; Konstantinos T Tsaousis; Vasilios F Diakonis; Artemis Matsou; Straton Tyradellis
Journal:  Eye Brain       Date:  2020-07-14

7.  Retinal Microvascular Change in Hypertension as measured by Optical Coherence Tomography Angiography.

Authors:  Woo Hyuk Lee; Jae-Hyeong Park; Yeokyoung Won; Min-Woo Lee; Yong-Il Shin; Young-Joon Jo; Jung-Yeul Kim
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

8.  Evaluation of retinal microvasculature according to stable chronic obstructive pulmonary disease severity and the correlation of pulmonary parameters with optical coherence tomography angiography findings.

Authors:  Bengi Ece Kurtul; Ayse Idil Cakmak; Ezgi Kasapoglu Dilek; Nursel Dikmen
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.